Literature DB >> 35859449

Chloroquine drops against SARS-CoV-2 infection.

Jogender Kumar1, Jitendra Meena1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35859449      PMCID： PMC9552387          DOI： 10.4103/ijmr.ijmr_1303_21

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN： 0971-5916            Impact factor:   5.274


× No keyword cloud information.
  3 in total

1.  Chloroquine nasal drops in asymptomatic & mild COVID-19: An exploratory randomized clinical trial.

Authors:  Alok Thakar; Smriti Panda; Pirabu Sakthivel; Megha Brijwal; Shivram Dhakad; Avinash Choudekar; Anupam Kanodia; Sushma Bhatnagar; Anant Mohan; Subir K Maulik; Lalit Dar
Journal:  Indian J Med Res       Date:  2021 Jan & Feb       Impact factor: 5.274

2.  The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials.

Authors:  Kimberley Lewis; Dipayan Chaudhuri; Fayez Alshamsi; Laiya Carayannopoulos; Karin Dearness; Zain Chagla; Waleed Alhazzani
Journal:  PLoS One       Date:  2021-01-06       Impact factor: 3.240

3.  Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.

Authors:  Jogender Kumar; Siddharth Jain; Jitendra Meena; Arushi Yadav
Journal:  J Infect Chemother       Date:  2021-02-22       Impact factor: 2.211
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.